+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
Diphtheria Market Report 2025 - Product Thumbnail Image

Diphtheria Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Aspergillosis Treatment Market Report 2025 - Product Thumbnail Image

Aspergillosis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Encephalitis Treatment Market Report 2025 - Product Thumbnail Image

Encephalitis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Antivirals Market Report 2025 - Product Thumbnail Image

Antivirals Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Systemic Aspergillosis and Systemic Candidiasis Market Report 2025 - Product Thumbnail Image

Systemic Aspergillosis and Systemic Candidiasis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Antiviral Combination Therapy Market Report 2025 - Product Thumbnail Image

Antiviral Combination Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Throat Cancer Therapeutics Market 2024-2028 - Product Thumbnail Image

Throat Cancer Therapeutics Market 2024-2028

  • Report
  • December 2023
  • 158 Pages
  • Global
From
From
From
Fibrodysplasia ossificans progressiva - Pipeline Insight, 2024 - Product Thumbnail Image

Fibrodysplasia ossificans progressiva - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cataract - Pipeline Insight, 2024 - Product Thumbnail Image

Cataract - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Central Serous Chorioretinopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Central Serous Chorioretinopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Heart Failure - Pipeline Insight, 2024 - Product Thumbnail Image

Heart Failure - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 300 Pages
  • Global
From
Loading Indicator